A Randomized, Controlled, Multicenter Phase 4 Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of Sabin-strain Inactivated Polio Vaccine (sIPV), Diphtheria, Tetanus, Pertussis (DTaP) Vaccine and Live Attenuated Hepatitis A Vaccine (HepA)
Latest Information Update: 07 Nov 2022
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; Hepatitis A vaccine live (Primary) ; Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary)
- Indications Diphtheria; Hepatitis A; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors China National Biotec Group
- 27 Nov 2020 New trial record